ArticleTherapeutic advances in medical oncology2023

Adjuvant trastuzumab and vinorelbine for early-stage HER2+ breast cancer.

Shannon McLaughlin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.